Sheets Smith Investment Management Takes $1.69 Million Position in GRAIL, Inc. $GRAL

Sheets Smith Investment Management acquired a new stake in shares of GRAIL, Inc. (NASDAQ:GRAL) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 28,558 shares of the company’s stock, valued at approximately $1,689,000.

Other hedge funds also recently bought and sold shares of the company. Teacher Retirement System of Texas boosted its position in GRAIL by 5.5% during the 2nd quarter. Teacher Retirement System of Texas now owns 8,538 shares of the company’s stock valued at $439,000 after acquiring an additional 447 shares in the last quarter. Parallel Advisors LLC lifted its stake in shares of GRAIL by 24.1% during the 2nd quarter. Parallel Advisors LLC now owns 2,313 shares of the company’s stock worth $119,000 after purchasing an additional 449 shares during the last quarter. Crown Wealth Group LLC boosted its position in GRAIL by 5.9% during the second quarter. Crown Wealth Group LLC now owns 8,986 shares of the company’s stock valued at $462,000 after purchasing an additional 500 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in GRAIL by 28.2% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,835 shares of the company’s stock valued at $76,000 after purchasing an additional 623 shares during the last quarter. Finally, HighTower Advisors LLC raised its holdings in GRAIL by 5.7% in the first quarter. HighTower Advisors LLC now owns 11,591 shares of the company’s stock worth $296,000 after purchasing an additional 627 shares in the last quarter.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on GRAL. Canaccord Genuity Group raised their price target on shares of GRAIL from $85.00 to $105.00 and gave the company a “buy” rating in a report on Monday, November 17th. UBS Group set a $75.00 target price on shares of GRAIL in a research note on Friday, October 3rd. Morgan Stanley lifted their price target on shares of GRAIL from $85.00 to $110.00 and gave the stock an “equal weight” rating in a report on Monday, December 1st. Guggenheim raised GRAIL from a “neutral” rating to a “buy” rating and set a $100.00 price target on the stock in a research report on Wednesday, November 12th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of GRAIL in a research report on Wednesday, October 8th. Two equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, GRAIL currently has an average rating of “Hold” and a consensus price target of $97.50.

Insider Buying and Selling at GRAIL

In related news, CEO Robert P. Ragusa sold 7,239 shares of the firm’s stock in a transaction on Wednesday, October 15th. The stock was sold at an average price of $68.88, for a total value of $498,622.32. Following the completion of the transaction, the chief executive officer owned 727,388 shares in the company, valued at $50,102,485.44. This trade represents a 0.99% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, President Joshua J. Ofman sold 81,385 shares of GRAIL stock in a transaction dated Monday, October 6th. The stock was sold at an average price of $62.50, for a total value of $5,086,562.50. Following the sale, the president directly owned 396,797 shares of the company’s stock, valued at approximately $24,799,812.50. This represents a 17.02% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 113,295 shares of company stock worth $7,380,888. 1.85% of the stock is owned by insiders.

GRAIL Trading Up 2.9%

NASDAQ:GRAL opened at $88.32 on Friday. The company has a market cap of $3.44 billion, a PE ratio of -7.59 and a beta of 4.23. GRAIL, Inc. has a twelve month low of $16.10 and a twelve month high of $115.76. The company’s 50 day moving average is $89.19 and its two-hundred day moving average is $58.04.

GRAIL (NASDAQ:GRAL) last posted its quarterly earnings results on Wednesday, November 12th. The company reported ($2.46) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($3.40) by $0.94. GRAIL had a negative net margin of 286.43% and a negative return on equity of 15.69%. The business had revenue of $36.19 million during the quarter, compared to analysts’ expectations of $33.83 million. As a group, analysts expect that GRAIL, Inc. will post -15.15 EPS for the current fiscal year.

GRAIL Company Profile

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.